Does OLAPARIB Cause Pancreatic carcinoma? 33 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 33 reports of Pancreatic carcinoma have been filed in association with OLAPARIB (Lynparza). This represents 0.2% of all adverse event reports for OLAPARIB.
33
Reports of Pancreatic carcinoma with OLAPARIB
0.2%
of all OLAPARIB reports
10
Deaths
2
Hospitalizations
How Dangerous Is Pancreatic carcinoma From OLAPARIB?
Of the 33 reports, 10 (30.3%) resulted in death, 2 (6.1%) required hospitalization, and 2 (6.1%) were considered life-threatening.
Is Pancreatic carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OLAPARIB. However, 33 reports have been filed with the FAERS database.
What Other Side Effects Does OLAPARIB Cause?
Death (4,378)
Malignant neoplasm progression (1,862)
Nausea (1,582)
Anaemia (1,455)
Fatigue (1,437)
Off label use (777)
Vomiting (642)
Drug ineffective (563)
Diarrhoea (514)
Asthenia (491)
What Other Drugs Cause Pancreatic carcinoma?
RANITIDINE (15,752)
SITAGLIPTIN (1,142)
PANCRELIPASE AMYLASE\PANCRELIPASE LIPASE\PANCRELIPASE PROTEASE (838)
EXENATIDE (781)
LIRAGLUTIDE (680)
METFORMIN\SITAGLIPTIN (431)
PACLITAXEL (325)
SEMAGLUTIDE (237)
DULAGLUTIDE (229)
ADALIMUMAB (213)
Which OLAPARIB Alternatives Have Lower Pancreatic carcinoma Risk?
OLAPARIB vs OLARATUMAB
OLAPARIB vs OLECLUMAB
OLAPARIB vs OLIVE OIL\SOYBEAN OIL
OLAPARIB vs OLMESARTAN
OLAPARIB vs OLMESARTAN MEDOXOMIL